Nicotine suppresses energy storage through activation of sympathetic outflow to brown adipose tissue via corticotropin-releasing factor type 1 receptor

Neuroscience Letters

Volumn 455, Issue 1, 2009, Pages 26-29

  Mano Otagiri, Asuka ^a   Iwasaki Sekino, Azusa ^a   Ohata, Hisayuki ^a   Arai, Keiko ^a   Shibasaki, Tamotsu ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Antalarmin; Brown adipose tissue; Corticotropin releasing factor type 1 receptor; Energy metabolism; Noradrenaline

Indexed keywords

ANTALARMIN; ANTISAUVAGINE 30; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; NICOTINE;

ARTICLE; BROWN ADIPOSE TISSUE; ENERGY BALANCE; ENERGY CONSERVATION; ENERGY EXPENDITURE; EXPERIMENTAL RAT; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; SYMPATHETIC TONE;

ADIPOSE TISSUE, BROWN; ANIMALS; ENERGY METABOLISM; INJECTIONS, INTRAPERITONEAL; MALE; NICOTINE; NOREPINEPHRINE; PYRIMIDINES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SYMPATHETIC NERVOUS SYSTEM;

EID: 63449122226     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.03.054     Document Type: Article

References (39)

1. Anderson K., Siegel R., Fuxe K., and Eneroth P. Intravenous injections of nicotine induce very rapid and discrete reductions of hypothalamic catecholamine levels associated with increases of ACTH, vasopressin and prolactin secretion. Acta. Physiol. Scand. 118 (1983) 35-40
2. Anderson K., Fuxe K., Eneroth P., Mascagni F., and Agnati L.F. Effects of acute intermittent exposure to cigarette smoke on cathecholamine levels and turnover in various types of hypothalamic DA and NA nerve terminal systems as well as on the secretion of adenohypophyseal hormones and corticosterone. Acta. Physiol. Scand. 124 (1985) 277-285
3. Arai K., Kim K., Kaneko K., Iketani M., Otagiri A., Yamauchi N., and Shibasaki T. Nicotine infusion alters leptin and uncoupling protein 1 mRNA expression in adipose tissues of rats. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E867-E876
4. Bale T.L., Anderson K.R., Roberts A.J., Lee K.F., Nagy T.R., and Vale W.W. Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold. Endocrinology 144 (2003) 2580-2587
5. Bamshad M., Song C.K., and Bartness T.J. CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am. J. Physiol. 276 (1999) R1569-R1578
6. Cam G.R., Bassett J.R., and Cairncross K.D. The action of nicotine on the pituitary-adrenal cortical axis. Arch. Int. Pharmacodyn. Ther. 237 (1979) 49-66
7. Cano G., Passerin A.M., Schiltz J.C., Card J.P., Morrison S.F., and Sved A.F. Anatomical substrates for the central control of sympathetic outflow to interscapular adipose tissue during cold exposure. J. Comp. Neurol. 460 (2003) 303-326
8. Cannon B., and Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Behav. 84 (2004) 277-359
9. Carlin K.M., Vale W.W., and Bale T.L. Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 3462-3467
10. Cerri M., and Morrison S.F. Corticotropin releasing factor increases in brown adipose tissue thermogenesis and heart rate through dorsomedial hypothalamus and medullary raphe pallidus. Neuroscience 140 (2006) 711-721
11. Deak T., Nguyen K.T., Ehrlich A.L., Watkins L.R., Spencer R.L., Maier S.F., Licinio J., Wong M.L., Chrousos G.P., Webster E., and Gold P.W. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 140 (1999) 79-86
12. Egawa M., Yoshimatsu H., and Bray G.A. Effect of corticotropin-releasing hormone and neuropeptide Y on electrophysiological activity of sympathetic nerves to interscapular brown adipose tissue. Neuroscience 34 (1990) 771-775
13. Frankish H.M., Dryden S., Wang Q., Bing C., MacFarlane I.A., and Williams G. Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine's effects on energy balance. Brain Res. 694 (1995) 139-146
14. Hastings J.A., McClure-Sharp J.M., and Morris M.J. NPY Y1 receptors exert opposite effects on corticotropin releasing factor and noradrenaline overflow from the rat hypothalamus in vitro. Brain Res. 890 (2001) 32-37
15. Huang L.Z., and Winzer-Serhan U.H. Nicotine regulates mRNA expression of feeding peptides in the arcuate nucleus in neonatal rat pups. Dev. Neurobiol. 76 (2007) 363-377
16. Katneni K., Charman S.A., and Porter C.J. Impact of cremophor-EL and polysorbate-80 on digoxin permeability across rat jejunum: delineation of thermodynamic and transporter related events using the reciprocal permeability approach. J. Pharm. Sci. 96 (2007) 280-293
17. Kremer P.R., Kramer S.F., Marr K., Guan G., Wellman P.J., and Bellinger L.L. Nicotine administration effects on feeding and cocaine-amphetamine-regulated transcript (CART) expression in the hypothalamus. Regul. Pept. 138 (2007) 66-73
18. LeFeuvre R.A., Rothwell N.J., and Stock M.J. Activation of brown fat thermogenesis in response to central injection of corticotropin releasing hormone in the rat. Neuropharmacology 26 (1987) 1217-1221
19. Li M.D., and Kane J.K. Effect of nicotine on the expression of leptin and forebrain leptin receptors in the rat. Brain Res. 991 (2003) 222-231
20. Loughlin S.E., Islas M.I., Cheng M.Y., Lee A.G., Villegier A.S., and Leslie F.M. Nicotine modulation of stress-related peptide neurons. J. Comp. Neurol. 497 (2006) 575-588
21. Lowell B.B., and Spiegelman B.M. Towards a molecular understanding of adaptive thermogenesis. Nature 404 (2000) 652-660
22. Luiten P.G., and Room P. Interrelations between lateral, dorsomedial and ventromedial hypothalamic nuclei in the rat. Brain Res. 190 (1980) 321-332
23. Luiten P.G., Ter Horst G.J., Karst H., and Steffens A.B. The course of paraventricular hypothalamic efferents to autonomic structures in medulla and spinal cord. Brain Res. 329 (1985) 374-378
24. Marty M.A., Erwin V.G., Cornell K., and Zgombick J.M. Effects of nicotine on β-endorphin, αMSH, and ACTH secretion by isolated perfused mouse brains and pituitary glands, in vitro. Pharmacol. Biochem. Behav. 22 (1985) 317-325
25. Masaki T., Yoshimichi G., Chiba S., Yasuda T., Noguchi H., Kakuma T., Sakata T., and Yoshimatsu H. Corticotropin-releasing hormone-mediated pathway of leptin to regulate adiposity, and uncoupling protein expression in mice. Endocrinology 144 (2003) 3547-3554
26. Matta S.G., Foster C.A., and Sharp B.M. Nicotine stimulates the expression of cFos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions. Endocrinology 132 (1993) 2149-2156
27. Moffatt R.J., and Owens S.G. Cessation from cigarette smoking: changes in body weight, body composition, resting metabolism and energy consumption. Metabolism 40 (1991) 814-817
28. Oldfield B.J., Giles M.E., Watson A., Anderson C., Colvill L.M., and Mckinley M.J. The neurochemical characterisation of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat. Neuroscience 110 (2002) 515-526
29. Perkins K.A., Epstein L.H., Marks B.L., Stiller R.L., and Jacob R.G. The effect of nicotine on energy expenditure during light physical activity. N. Engl. J. Med. 320 (1989) 898-903
30. Richard D., Lin Q., and Timofeeva E. The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance. Eur. J. Pharmacol. 440 (2002) 189-197
31. Sarkar S., Légrádi G., and Lechan R.M. Intracerebroventricular administration of α-meranocyte-stimulating hormone increases phosphorylation of CREB in TRH- and CRH-producing neurons of the hypothalamic paraventricular nucleus. Brain Res. 945 (2002) 50-59
32. Schulz D.W., Mansbach R.S., Sprouse J., Braselton J.P., Collins J., Corman M., Dunaiskis A., Faraci S., Schmidt A.W., Seeger T., Seymour P., Tingley III F.D., Winston E.N., Chen Y.L., and Heym J. CP-154, 526: A potent and selective nonpeptide antagonist of corticotropin-releasing factor receptors. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 10477-10482
33. Sekino A., Ohata H., Mano-Otagiri A., Arai K., and Shibasaki T. Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats. Psychopharmacology 176 (2004) 30-38
34. Shibasaki T., Yamauchi N., Kato Y., Masuda A., Imaki T., Hotta M., Demura H., Oono H., Ling N., and Shizume K. Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat. Life Sci. 43 (1988) 1103-1110
35. Suda T., Tozawa F., Iwai I., Sato Y., Sumitomo T., Nakano Y., Yamada M., and Demura H. Nueropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Brain Res. Mol Brain Res. 18 (1993) 311-315
36. Ter Horst G.J., and Luiten P.G. Phaseolus vulgalis leuco-agglutinin tracing of intrahypothalamic connections of the lateral, ventromedial, dorsomedial and paraventricular hypothalamic nuclei in the rat. Brain Res. Bull. 18 (1987) 191-203
37. Valentine J.D., Matta S.G., and Sharp B.M. Nicotine-induced cFos expression in the hypothalamic paraventricular nucleus is dependent on brainstem effects: correlations with cFos in catecholaminergic and noncatecholaminergic neurons in the nucleus tractus solitarius. Endocrinology 137 (1996) 622-630
38. Webster E.L., Lewis D.B., Torpy D.J., Zachman E.K., Rice K.C., and Chrousos G.P. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137 (1996) 5747-5750
39. Yoshimatsu H., Egawa M., and Bray G.A. Sympathetic nerve activity after discrete hypothalamic injections of l-glutamate. Brain Res. 601 (1993) 121-128